Sandu Pharmaceuticals Ltd
Incorporated in 1985, Sandu Pharmaceuticals Ltd manufactures and trades Ayurvedic proprietary medicines.
- Market Cap ₹ 47.3 Cr.
- Current Price ₹ 49.0
- High / Low ₹ 67.5 / 43.8
- Stock P/E 30.5
- Book Value ₹ 43.5
- Dividend Yield 1.63 %
- ROCE 5.44 %
- ROE 3.75 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.13 times its book value
Cons
- Company has a low return on equity of 3.80% over last 3 years.
- Promoter holding has decreased over last 3 years: -7.53%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
65.50 | 65.35 | 67.28 | 67.19 | |
62.62 | 62.87 | 64.98 | 64.43 | |
Operating Profit | 2.88 | 2.48 | 2.30 | 2.76 |
OPM % | 4.40% | 3.79% | 3.42% | 4.11% |
0.08 | 0.33 | 0.42 | 0.17 | |
Interest | 0.11 | 0.08 | 0.06 | 0.10 |
Depreciation | 0.53 | 0.52 | 0.58 | 0.67 |
Profit before tax | 2.32 | 2.21 | 2.08 | 2.16 |
Tax % | 31.47% | 31.22% | 29.33% | 28.24% |
1.59 | 1.52 | 1.46 | 1.55 | |
EPS in Rs | 1.80 | 1.57 | 1.51 | 1.60 |
Dividend Payout % | 41.56% | 0.00% | 52.93% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 1% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -1% |
TTM: | 6% |
Stock Price CAGR | |
---|---|
10 Years: | 6% |
5 Years: | 16% |
3 Years: | -11% |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 4% |
Last Year: | 4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Equity Capital | 8.81 | 9.66 | 9.66 | 9.66 |
Reserves | 27.66 | 29.58 | 30.93 | 32.36 |
0.00 | 0.00 | 0.00 | 0.48 | |
12.81 | 14.93 | 11.82 | 13.22 | |
Total Liabilities | 49.28 | 54.17 | 52.41 | 55.72 |
16.00 | 16.62 | 17.88 | 18.15 | |
CWIP | 0.48 | 0.42 | 0.00 | 0.00 |
Investments | 9.11 | 9.65 | 10.42 | 11.22 |
23.69 | 27.48 | 24.11 | 26.35 | |
Total Assets | 49.28 | 54.17 | 52.41 | 55.72 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
0.95 | 0.22 | 0.76 | 0.95 | |
-5.47 | 0.54 | -1.31 | -0.19 | |
0.93 | 0.58 | -0.72 | -0.46 | |
Net Cash Flow | -3.59 | 1.34 | -1.27 | 0.30 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|
Debtor Days | 22.23 | 26.75 | 26.42 | 25.86 |
Inventory Days | 115.06 | 167.70 | 137.28 | 160.90 |
Days Payable | 69.63 | 98.30 | 47.07 | 51.05 |
Cash Conversion Cycle | 67.67 | 96.15 | 116.63 | 135.70 |
Working Capital Days | 42.41 | 52.33 | 56.69 | 62.80 |
ROCE % | 6.05% | 5.36% | 5.44% |
Documents
Announcements
-
Announcement Under Regulation 30-Update-Show Cause Notice [U/S 9(2) Of The Maharashtra Tax On Professions, Trades, Callings And Employments Act, 1975] Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
8 Sep - Received show-cause notice for late Maharashtra profession tax payments; interest INR 14,689; received 08-09-2025.
- Newspaper Publication Post Dispatch Notice Of Annual General Meeting And Evoting Instructions 7 Sep
-
Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTA
6 Sep - AGM Sep 30, 2025; annual report weblink; transfer window Jul7–Jan6; Saksham Niveshak Jul28–Nov6, 2025.
-
Notice Of The 40Th Annual General Meeting Of Sandu Pharmaceuticals Limited To Be Held On 30Th September 2025
6 Sep - 40th AGM on 30 Sep 2025; proposes 8% dividend, RPT approval up to ₹100 crore.
- Reg. 34 (1) Annual Report. 6 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Portfolio:[1]
Company manufactures over 100 types of products, including oils, syrups, granules, powder, and avlehas, which are marketed under the Sandu brand viz, Sandu Ashoka Compound, Sandu Abhayarishta, Sandu Arvindasav, Sandu Balant Kadha No. 1, Sandu Debix Tablet, Sandu Bhunimbadi Kadha, Sandu Chandanasav Syrup, Sandu Chandraprabha, Sandu Chyavanprash Special, Sandu Dadimavaleha, etc.